Glenmark Pharma reaches settlement agreement with Pfizer for Axitinib tablets

Glenmark Pharma has reached a settlement agreement with Pfizer for Axitinib tablets, 1 mg and 5 mg, the generic version of their Inlyta1 tablets, 1 mg and 5 mg, a statement from Glenmark Pharma said.

The company (Glenmark Pharma) earlier had also received tentative approval by the US Food and Drug Administration (FDA) for their generic Axitinib tablets, 1 mg and 5 mg on 30th November, 2020.